RxDoctor Payments Data

Lisa Speer, APRN

Family · Conway, ARNPI 1609466473

Payments from drug & device makers

$2,668in general payments, 2019–2025

Across 160 payments — averaging $16.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Mayne Pharma Commercial LLC$379
  • AbbVie$376
  • Bayer$264
  • Astellas Pharma US Inc$240
  • Pfizer$195
  • Organon$133
  • plus $1K from 25 others

What the payments were for

  • Food & beverage$2,41791%
  • Education$2519%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,668 in reported general payments places this provider in the 85th percentile of 2,103 family providers in Arkansas.

See all family providers in Arkansas

Medicare billing

Part B allowed, 2024
$2,677
Medicare patients
46
Services billed
65

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
PremarinEstrogens, Conjugated22$5,787
Estradiol198$5,037
ValacyclovirValacyclovir Hcl19$891
Estradiol (Twice Weekly)Estradiol15$551
ProgesteroneProgesterone, Micronized43$496
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip16$286
Clobetasol Propionate11$197
Fluconazole20$113
Raloxifene Hcl14$75
Venlafaxine Hcl ErVenlafaxine Hcl25$71

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerPremarin$195$5,78722 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,103 family providers in Arkansas.

Other family in Conway

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →